Report Details:
15 Companies Covered
115 Pages
Optical Coherence Tomography Market Highlights
The Optical Coherence Tomography Market reached USD 2.08 billion in 2025 and opens the forecast window at USD 2.32 billion in 2026, climbing to USD 6.23 billion by 2035 at an 11.6% CAGR.
Optical Coherence Tomography (OCT) is a non-invasive imaging technique that uses light waves to capture high-resolution cross-sectional images of biological tissues. It is commonly used in ophthalmology for retinal imaging but has applications in other medical fields such as cardiology, dermatology, and gastroenterology.
Segment Analysis
The global Optical Coherence Tomography Market has been segmented based Technology, Application, Type of Devices
Based on technology, the market segments of optical coherence tomography includes Sd-Oct and Swept-Source Oct. The Sd-Oct segment held the majority share in 2024, contributing around ~65-67% to the market revenue of optical coherence tomography. Sd-Oct is an interferometric technology capable of providing depth-resolved tissue data structures encrypted in the scale and deferral of backscattered light by analyzing the spectrum of the sequence of the interference fringe.
Based on application, the optical coherence tomography market segmentation includes cardiology, ophthalmology, and dermatology. The ophthalmology segment dominated the market in 2024 and is projected to be the faster-growing segment during the forecast period, 2025-2035. Ophthalmology is expected to increase as the incidence of choroidal and retinal disorders rises, leading to increased use of optical coherence tomography imaging and diagnostic devices by ophthalmologists.
The optical coherence tomography market data has been bifurcated by type of devices into handheld, tabletop, and catheter-based Oct devices. The handheld segment dominated the market in 2024 and is projected to be the faster-growing segment during the forecast period 2025-2035. Handheld OCT devices use Microelectromechanical Systems (MEMS) and 3D imaging to assist in the early detection of various eye disorders, including macular degeneration, diabetic retinopathy, and glaucoma.
Therefore, the management of bedside monitoring will be enhanced by portable OCT devices in the coming years. As a result, this segment's profitable growth can be attributed to increased demands for pharmacokinetic services to help with toxicology tests for IND-enabling studies.
Regional Analysis
The global Optical Coherence Tomography Market , based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World . The North American Optical Coherence Tomography market accounted for USD 1.05 billion in 2024 and is expected to exhibit a significant CAGR growth during the study period. The region's growth is fueled by a growing senior population, increased approvals and R&D investments, a preference for adopting newer products in the United States, hospital expansion, and a well-established healthcare infrastructure.
The European optical coherence tomography market accounts for the second-largest market share, owing to increased awareness about the early detection of glaucoma and other diseases associated with ocular eye pressure and market adoption of new products.
For example, according to the Prevalence & Incidence of Diabetic Retinopathy (DR) in the U.K. Population of Gloucestershire, in May 2021, 35,873 adults with diabetes underwent at least one diabetic retinopathy examination. In Europe, optical coherence tomography has proven helpful in various medical fields, especially ophthalmology.
The Asia-Pacific Optical Coherence Tomography Market is expected to grow at the fastest CAGR from 2025 to 2035. The rapid regional growth can be attributed to several factors, including an increase in the prevalence of chronic diseases, increased adoption of advanced technologies, a large senior population pool, increased reimbursement for surgical procedures, and a strong preference for minimally invasive procedures over traditional methods.
Besides, rising awareness about eye disorders is expected to drive the Asia Pacific optical coherence tomography industry growth throughout the forecast period. Moreover, China’s market of optical coherence tomography held the largest market share, and the Indian market of optical coherence tomography was the fastest-growing market in the Asia-Pacific region.
Key Players:
MRFR recognizes the following companies as the key players in the global Optical Coherence Tomography Market — Carl Zeiss AG, Alcon, Abbott Laboratories, Terumo Corporation, Koninklijke Philips N.V., Braun Melsungen AG, Boston Scientific Corporation, Topcon Corporation, NIDEK Co. Ltd, Novacam Technologies Inc
Key Findings of the Study
- North America accounts for 35.4% of the Optical Coherence Tomography Market in 2025
- Asia-Pacific posts a 14.3% CAGR across the forecast window
- Europe contributes USD 0.56 billion in 2025
